Audit finds gaps in state tracking of opioid abuse
Oregon's prescription drug monitoring program doesn't measure up to those in other states.
- Published in Health Care
Benefit Company label marred by confusion and lax reporting practices
In Oregon and elsewhere, benefit companies go largely unregulated.
- Published in Energy and Environment